DISCLOSURE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS), REGULATIONS 2015("LISTING REGULATION ")READ WITH INDUSTRY STANDARDS ON LISTING REGULATION-SUMMARY ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd held an Extra-Ordinary General Meeting on July 22, 2025 at 4:00 PM via video conferencing, which concluded at 4:13 PM. The meeting was chaired by Mr. Sameer Goel, Managing Director and CEO, with requisite quorum confirmed. Two ordinary resolutions were considered: (1) regularization of the Statutory Auditor (M/s Neeraj Arora & Associates), and (2) regularization of an Additional Director. Shareholders who participated praised the company's performance and appreciated the Board's transparency and stakeholder engagement. Voting was conducted via NSDL's remote e-voting facility (July 19-21, 2025) and at-meeting e-voting. The voting results and Scrutinizer's report will be submitted to the stock exchanges within the regulatory timeline.
This is a routine procedural filing confirming the EGM was held as scheduled and standard corporate items were put to vote. The actual outcome (approval/rejection of the auditor and director regularization) is pending the Scrutinizer's report, so no immediate material impact on shareholders. Shareholders should watch for the voting results filing for confirmation.